World Orphan Drug Congress Asia 2017

 

21 March 2017

World Orphan Drug Congress Asia 2017

 

An Industry Partnership with:

 

JTC Corporation

 

QUALITY CARE FOR RARE DISEASE PATIENTS IN ASIA

 

WHAT IS THE WORLD ORPHAN DRUG CONGRESS ASIA?

 

THE ONLY RARE DISEASE MEETING IN ASIA

Gain insights into expediting orphan drug development & guaranteeing speedy reimbursement in Asia's market.

 

Join a series of thought-provoking discussions ranging from discovery to clinical development, manufacturing, licensure & product launch.

VIEW THE AGENDA

THE PLATFORM TO ACCESS ASIA'S MARKET

Bringing together specialised biotechs/pharmas, government, payers, investors & patient groups in one platform, this event offers a unique opportunity to increase brand visibility amongst the rare disease industry in Asia.

Position yourself as a leader by delivering a keynote presentation or securing an exhibition booth.

SPONSORSHIP OPPORTUNITIES

 

World Orphan Drug Congress Asia is a part of:

Confirmed patient groups

2017 Speakers

  • Edmund Lim at World Orphan Drug Congress Asia 2017
    Edmund Lim
    Co-founder
    We CARE Journey
  • Cynthia Magdaraog at World Orphan Drug Congress Asia 2017
    Cynthia Magdaraog
    Philippine Society for Orphan Disorders
    Philippine Society for Orphan Disorders
  • Mr Kenneth Mah at World Orphan Drug Congress Asia 2017
    Mr Kenneth Mah
    Executive Director
    Rare Disorders Society (Singapore)
  • Dr Carmencita D Padilla at World Orphan Drug Congress Asia 2017
    Dr Carmencita D Padilla
    Founding Chairman
    Philippine Society for Orphan Disorders
  • Ravdeep Singh Anand at World Orphan Drug Congress Asia 2017
    Ravdeep Singh Anand
    Founder - President
    Dystrophy Annihilation Research Trust
  • Hazel Gorham at World Orphan Drug Congress Asia 2017
    Hazel Gorham
    Senior Director of Biosimilars Development
    PRA Health Sciences
  • Carolyn Anne Hall at World Orphan Drug Congress Asia 2017
    Carolyn Anne Hall
    Head of Patient Service APAC
    Shire
  • Terry Lai at World Orphan Drug Congress Asia 2017
    Terry Lai
    Vice Chairman
    HKMPS
  • John Lim at World Orphan Drug Congress Asia 2017
    John Lim
    Executive Director
    Duke-NUS Centre of Regulatory Excellence (CoRE)
  • Rajakanth R at World Orphan Drug Congress Asia 2017
    Rajakanth R
    Executive Director
    Rainbow Across Borders Limited
  • Chien Yeh Wong at World Orphan Drug Congress Asia 2017
    Chien Yeh Wong
    Chief Pharmacist/Director
    Alliance Pharm
  • Teik Lee Yu at World Orphan Drug Congress Asia 2017
    Teik Lee Yu
    Regional Marketing Lead (Rare Diseases-Pompe), Emerging Markets
    Sanofi Singapore
  • Young Joo PARK at World Orphan Drug Congress Asia 2017
    Young Joo PARK
    Senior Director, Business Development & Global Cooperation
    KoNECT
  • Catherine Jayasuriya at World Orphan Drug Congress Asia 2017
    Catherine Jayasuriya
    Executive Director of Coalition Duchenne Director
    Coalition Duchenne
  • Hans-Peter Guler at World Orphan Drug Congress Asia 2017
    Hans-Peter Guler
    SVP, Clinical Development
    INC Research
  • Dr Maria Melanie Liberty Alcausin at World Orphan Drug Congress Asia 2017
    Dr Maria Melanie Liberty Alcausin
    Director, Newborn Screening Reference Center
    National Institutes of Health, University Of The Philippines Manila

"It is the only pan-indication rare disease meeting in Asia and a great place to meet potential clients and collaborators."

Comradis

4 CONFERENCE THEMES

FASTER & CHEAPER ACCESS TO ORPHAN DRUGS
 

COUNTRY PERSPECTIVE: SUPPORTING ORPHAN DRUG ACCESS

BENEFIT VS. COST & STANDARD OF CARE
 

EARLY DIAGNOSIS


 

 

Who Attends?

 

  A*S.T.A.R. Singapore Immunology Network   A.F.T. Orphan   Actelion   Actelion Pharmaceuticals   Alexion Pharmaceuticals Australasia Pty Ltd   Alnylam Pharmaceuticals   AMICULUM   Amiculum Consulting   Asklepion Pharmaceuticals LLC   AstraZeneca   ASUS Computer International   Australian Government   AxxessBio Pte Ltd   B.T.I   Baxalta   Baxalta Singapore Pte Ltd   Bayer   Bayer Healthcare   Beijing Genome Institute   Beijing Yuan Tang Institute Of Gene Science   Biogen Idec   BioMarin   BioMarin Pharmaceutical Inc.   Bioneur   Bioprocessing Technology Institute Singapore   Biovalence S/B   Boston Consulting Group   Bristol-Myers Squibb   C.M.I.C. Holdings Co Ltd   Carcinoid & Neuroendocrine Tumor Society   Centogene India Pvt Ltd   Chinese Organization for Rare Disorders   Cimbria As   Clinical Nutrition Research Centre NUS   Clinigen Group plc   Club Rainbow   Comradis   Cote Orphan Consulting   Cytonet Gmbh   DEBRA   DEBRA International   Dipharma SA   Dipharma SA   Edimer Pharmaceuticals Inc   Eisai Clinical Research Singapore Pte Ltd   Eisai Pharmaceuticals India Pte.   Eli Lilly   Emerge Health Pty Ltd   Equisnzaroo   Esthelis Clinic   Excelsior Biopharma Inc.   Food and Drug Administration   Fuld & Company   Genome Institute of Singapore   Genzyme   Genzyme A Sanofi Company   Genzyme Korea   Genzyme Singapore Pte Ltd   GlaxoSmithKline   GNI Ltd. and Shanghai Genomics   H.A.E.i International Patient Organization for C1   Hong Kong Mucopolysaccharidoses & Rare Diseases Mutual Aid Group   HongKong Polytechnic University   Institute for Optimizing Health Outcomes   Institute of Medical Biology, A*STAR   Integrated Development Associates   J.C.R. Pharmaceuticals Co Ltd   King Baudouin Foundation   Korea Organization for Rare Diseases   Korea Orphan Drug Center   Licensing & Development   LINK Healthcare   LSD Support Society   Malaysia Lysosomal Diseases Association   Malaysia Metabolic Society   Malaysian Rare Disorders Society   Medicines Australia   Merck Sharp & Dohme   Ministry of Health   Ministry of Health Malaysia Pharmaceutical Services Division   Muscular Dystrophy Foundation India   Nanolek LLC   National Health Insurance Administration, Ministry of Health and Welfare   National Institutes of Health   National University Of Singapore   New Zealand Organisation for Rare Disorders   Nobelpharma Co., Ltd.   Novartis   Novartis Pharmaceuticals (HK) Limited   Novena Cancer Centre   Orphan Druganaut Blog   Orphan Europe   Orphan Trust Japan Co., Ltd.   Osaka University   P.B.L. Solutions   Pfizer Private Limited   Pharm-D   Phebra Pty Ltd   Plus One HealthCare Consulting   Project Manager   PTC Therapeutics   Quintiles East Asia Pte Ltd   Rare Disorders Society (Singapore)   Rare Genomic Asia   Rare Genomics Institute   ReGenXBio   Royal Holloway, University of London   Sanofi   Sanofi-Aventis Singapore Pte Ltd   SGPharma Pvt. Ltd.   Shionogi   Shire   Shire AG   Shire Australia   Shire Hgt   Shire Pharmaceuticals Inc   Shire Singapore Pte Ltd   Singapore Immunology Network (SIgN)   Singapore Immunology Network, ASTAR   Social Security Association   Society of Rare Disorders (Japan)   Stiefel, a GSK company   Supporting Organization for Patients with Rare Diseases (SORD)   SymBio Pharmaceuticals Limited   Taho Pharmaceuticals   Taiwan Foundation for Rare Diseases (TFRD)   Tanner Pharma Group   Thailand Fda   Toho Orphan Reliance   Transmedic Healthcare   Transmedic Pte Ltd   Tunghai University / Chung Gung University / Toastmasters International (NGO)   U.S. Hereditary Angioedema Association   Universiti Kebangsaan Malaysia   Valentech Pharma   Valiant Biopharma Sdn Bhd  

 

DOWNLOAD THE BROCHURE

"Such meetings are necessary for the development of the Orphan Drug market in Asia"

LSD Support Society

Position yourself as the thought leader

 

If you offer solutions to improve medical care of rare disease patients in the Asia-Pacific region, join us!

 

Customised sponsorship packages available to meet your marketing and business needs.

 

DOWNLOAD BROCHURE

In collaboration with
 

JTC Corporation 

Partner Association
 

Rainbow Across Borders 

Organised by
 

 

 

Get Involved

 

If you’d like to become an exhibitor, sponsor or speaker at the event

Contact Pinky Fadullon at pinky.fadullon@terrapinn.com
or +65 6322 2738